Madison Muller
speaker
81 appearances
19 recordings
1 series
first heard Feb 2026
last heard 19 Aug
Madison Muller’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 19 in all, peaking in Aug 2026 with 10.
Appearances
Bloomberg News Now · Reps on Epstein File Redactions, Trump on US Economy, More · 10 Feb 2026
podcast
Novo is saying that HIMSS is violating that patent in the United States.
Novo is suing on the grounds of patent infringement, which is something we haven't seen before.
Novo and Lilly have both filed lawsuits against compounding pharmacies, telehealth companies, med spas that are selling these knockoff versions of the drugs, but they haven't gone after anyone for patent infringement yet.
So this is actually the drug semaglutide, which is the active ingredient in both Ozempic and Wagovi.
Novo is saying that HIMS is violating that patent in the United States.
Bloomberg News Now · Epstein Files Review, Trump Predicts Growth Under Warsh, More · 10 Feb 2026
podcast
Novo is suing on the grounds of patent infringement, which is something we haven't seen before.
Novo and Lilly have both filed lawsuits against compounding pharmacies, telehealth companies, med spas that are selling these knockoff versions of the drugs, but they haven't gone after anyone for patent infringement yet.
So this is actually the drug semaglutide, which is the active ingredient in both Ozempic and Wagovi.
Novo is saying that HIMSS is violating that patent in the United States.
Novo is suing on the grounds of patent infringement, which is something we haven't seen before.
Novo and Lilly have both filed lawsuits against compounding pharmacies, telehealth companies, med spas that are selling these knockoff versions of the drugs, but they haven't gone after anyone for patent infringement yet.
So this is actually the drug semaglutide, which is the active ingredient in both Ozempic and Wagovi.
Novo is saying that HIMS is violating that patent in the United States.
Novo is suing on the grounds of patent infringement, which is something we haven't seen before.
Novo and Lilly have both filed lawsuits against compounding pharmacies, telehealth companies, med spas that are selling these knockoff versions of the drugs, but they haven't gone after anyone for patent infringement yet.
So this is actually the drug semaglutide, which is the active ingredient in both Ozempic and Wagovi.
Novo is saying that HIMS is violating that patent in the United States.
Novo is suing on the grounds of patent infringement, which is something we haven't seen before.
Novo and Lilly have both filed lawsuits against compounding pharmacies, telehealth companies, med spas that are selling these knockoff versions of the drugs, but they haven't gone after anyone for patent infringement yet.
So this is actually the drug semaglutide, which is the active ingredient in both Ozempic and Wagovi.
Showing 61–80 of 81 · page 4 of 5
← Previous
Next →